The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current ...
Researchers at AACR described the development of a classifier that identified a proportion of tumor samples with HRD that did not have BRCA1/2 mutations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results